Carl Icahn Sues Amylin Pharmaceuticals, Pushes for Sale

Carl Icahn sued Amylin Pharmaceuticals to block enforcement of a bylaw that prevents the billionaire investor from launching a proxy fight that could lead to a sale of the maker of diabetes drugs.
International Business Times